Our Research
At the Jacobs School, we advance research and discovery to improve health for all. Our multidisciplinary research advances basic and clinical science; we translate those discoveries into clinical care that improves health in our communities. With our eyes on the future, we are increasing the number of students and trainees who pursue careers in research, biomedical science and academic medicine.
Learn More About Our Research
Our Experts in the News
Recent Publications
- Egede LE, Campbell JA, Walker RJ, Fraser RA, Ekwunife O. (2025) Understanding the Roles of Fatalism and Self-Efficacy on Clinical and Behavioral Outcomes for African American with Type 2 Diabetes: A Systematic Review. Current diabetes reports (May), 25(1): 31.
- Oubraim S, Fauzan M, Studholme K, Gordon C, Glaser ST, Shen RY, Ojima I, Kaczocha M, Haj-Dahmane S. (2025) Astrocytic FABP5 mediates retrograde endocannabinoid transport at central synapses. iScience (May), 28(5): 112342. doi:10.1016/j.isci.2025.112342
- Rialon KL, Smith C, Rentea RM, Acker SN, Baird R, Beres AL, Chang HL, Christison-Lagay ER, Diesen DL, Englum BR, Gonzalez KW, Gulack BC, Ham PB, Huerta CT, Kulaylat AN, Levene TL, Lucas DJ, Mansfield SA, Pennell C, Ricca RL, Sulkowski JP, Tashiro J, Wakeman D, Yousef Y, Kelley-Quon LI, Kawaguchi A, . (2025) Functional Outcomes for Patients With Congenital Anorectal Malformations: A Systematic Review and Evidence-based Guideline From the APSA Outcomes and Evidence Based Practice Committee. Journal of pediatric surgery (May), 60(5): 162243.
Recent Research Funding
- A phase 3 double-blind study to evaluate the efficacy and safety of oral ozanimod compared to oral fingolimod in children and adolescents with relapsing-remitting multiple sclerosis. Michael Dwyer, III (Co-Investigator). Bristol Myers Squibb. $1,649,376. 6/1/2023-12/1/2032.
- CTSA State University of New York at Buffalo. Zackary Falls (Contributor). National Center for Advancing Translational Sciences (NCATS). $29,204,726. 1/1/2025-12/1/2031.
- Clinical and Translational Science Award. Core Operations Special Populations. Ralph Benedict (Co-Investigator). NIH. $29,204,726. 1/1/2025-12/1/2031.
- Clinical and Translational Science Award. University at Buffalo Clinical and Translational Science Institute. Timothy Murphy (Principal Investigator). NIH. 1/1/2025-12/1/2031.
- Molecular Physiology of NMDA Receptors. Gabriela Popescu (Principal Investigator). NINDS. $4,200,000. 5/1/2023-4/1/2031.